(Q48772014)

15 February 2018

title

Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain. (English)

1 reference

15 February 2018

1 reference

6

1 reference

15 February 2018

author name string

Jarmo Hietala

1

1 reference

15 February 2018

Mikko J Nyman

2

1 reference

15 February 2018

Olli Eskola

3

1 reference

15 February 2018

Aki Laakso

4

1 reference

15 February 2018

Tove Grönroos

5

1 reference

15 February 2018

Jörgen Bergman

7

1 reference

15 February 2018

Merja Haaparanta

8

1 reference

15 February 2018

Sarita Forsback

9

1 reference

15 February 2018

Päivi Marjamäki

10

1 reference

15 February 2018

Pertti Lehikoinen

11

1 reference

15 February 2018

Michael Goldberg

12

1 reference

15 February 2018

Donald Burns

13

1 reference

15 February 2018

Terence Hamill

14

1 reference

15 February 2018

Wai-Si Eng

15

1 reference

15 February 2018

Alexandre Coimbra

16

1 reference

15 February 2018

Richard Hargreaves

17

1 reference

15 February 2018

Olof Solin

18

1 reference

15 February 2018

publication date

1 July 2005

1 reference

15 February 2018

Molecular Imaging and Biology

published in

1 reference

15 February 2018

volume

7

1 reference

15 February 2018

issue

4

1 reference

15 February 2018

page(s)

262-272

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s11307-005-7001-6

exact match

0 references

cites work

An unidentified depressor substance in certain tissue extracts

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11307-005-7001-6

Compartmental Analysis of Diprenorphine Binding to Opiate Receptors in the Rat in vivo and its Comparison with Equilibrium Data in vitro

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11307-005-7001-6

The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11307-005-7001-6

Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus

21 January 2018

1 reference

12 December 2020

Distribution of substance P-like immunoreactivity in the central nervous system of the rat—I. Cell bodies and nerve terminals

1 reference

12 December 2020

Reproducibility of [11 C]FLB 457 binding in extrastriatal regions

1 reference

12 December 2020

Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK1 receptor quantitation: ([18F]SPA-RQ).

1 reference

12 December 2020

Substance P receptor-immunoreactive neurons in the rat neostriatum are segregated into somatostatinergic and cholinergic aspiny neurons

1 reference

12 December 2020

Neuropeptides and NADPH-diaphorase activity in the ascending cholinergic reticular system of the rat.

1 reference

12 December 2020

The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

1 reference

12 December 2020

Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus

1 reference

12 December 2020

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

1 reference

12 December 2020

Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression

1 reference

12 December 2020

Substance P serum levels are increased in major depression: preliminary results

1 reference

12 December 2020

Neurokinin receptor mRNA localization in human midbrain dopamine neurons.

1 reference

12 December 2020

Distribution of the substance P receptor (NK-1 receptor) in the central nervous system

1 reference

12 December 2020

Increased neurogenesis and brain‐derived neurotrophic factor in neurokinin‐1 receptor gene knockout mice

1 reference

12 December 2020

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 St

1 reference

12 December 2020

Quantification of [Carbonyl-11C]WAY-100635 binding: considerations on the cerebellum

1 reference

12 December 2020

Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers

1 reference

12 December 2020

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

12 December 2020

The selective neurokinin (NK)(1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study

1 reference

12 December 2020

Neurotransmitter functions of mammalian tachykinins

1 reference

12 December 2020

Altered nociception, analgesia and aggression in mice lacking the receptor for substance P

1 reference

12 December 2020

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.

1 reference

12 December 2020

Expression of substance P receptor in the substantia nigra.

1 reference

12 December 2020

1 reference

12 December 2020

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

1 reference

12 December 2020

Molecular cloning, structural characterization and functional expression of the human substance P receptor

1 reference

12 December 2020

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

12 December 2020

Serotonin-, substance P- and glutamate/aspartate-like immunoreactivities in medullo-spinal pathways of rat and primate

1 reference

12 December 2020

Neuropeptides--an overview.

1 reference

12 December 2020

The expression of neurokinin-1 receptor at striatal and pallidal levels in normal human brain.

1 reference

12 December 2020

Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions.

1 reference

12 December 2020

Modulation of cortical acetylcholine release by serotonin: the role of substance P interneurons.

1 reference

12 December 2020

Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.

1 reference

12 December 2020

Simplified reference tissue model for PET receptor studies.

1 reference

12 December 2020

Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding

1 reference

12 December 2020

Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor

1 reference

12 December 2020

Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity.

1 reference

12 December 2020

5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.

1 reference

12 December 2020

Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists.

1 reference

12 December 2020

Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra

1 reference

12 December 2020

Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant

1 reference

12 December 2020

The substance P antagonist L-760,735 inhibits stress-induced NK(1) receptor internalisation in the basolateral amygdala

1 reference

12 December 2020

Elevation of substance P-like peptides in the CSF of psychiatric patients

1 reference

12 December 2020

Neurokinin(1) receptor antagonists as potential antidepressants

1 reference

12 December 2020

Autoradiographic localisation of substance P (NK1) receptors in human primary visual cortex

1 reference

12 December 2020

Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists

1 reference

12 December 2020

Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain

1 reference

12 December 2020

A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor

1 reference

12 December 2020

Substance P receptors: Localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand

1 reference

12 December 2020

Automated synthesis and purification of [18F]bromofluoromethane at high specific radioactivity

1 reference

12 December 2020

Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET.

1 reference

12 December 2020

Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene

1 reference

12 December 2020

Serotonin and substance P co-exist in dorsal raphe neurons of the human brain

1 reference

12 December 2020

Striatal neurones displaying substance P (NK 1) receptor immunoreactivity in human and non-human primates

1 reference

12 December 2020

Substance P in the human brain

1 reference

12 December 2020

Cholinergic neurons expressing substance P receptor (NK(1)) in the basal forebrain of the rat: a double immunocytochemical study

1 reference

12 December 2020

Rewarding effects of opiates are absent in mice lacking the receptor for substance P.

1 reference

12 December 2020

Substance P and substance P receptors in bone and gingival tissues

1 reference

12 December 2020

Distribution of substance P-like immunoreactive structures in the brainstem of the adult human brain: an immunocytochemical study

1 reference

12 December 2020

Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy

1 reference

12 December 2020

Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain

1 reference

12 December 2020

Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume.

1 reference

12 December 2020

10.1007/S11307-005-7001-6

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018